• 31/10/2019

    3HP regimen soon to be accessible in Malawi

    KNCV Tuberculosis Foundation Malawi welcomes the substantial reduction in the price of the anti-tuberculosis drug rifapentine, announced today at the…

    Lees meer

  • 31/10/2019

    Important price reduction improves access to TB prevention

    KNCV Tuberculosis Foundation welcomes the announcement of a substantial reduction in the price of an anti-tuberculosis medicine through the support…

    Lees meer

  • 25/09/2019

    Innovative TB treatment support project kicks off in the Philippines

    ASCENT aims to assist patients succeed in treatment using digital adherence technology. On World Lung Day, the innovative TB treatment…

    Lees meer

  • 01/09/2019

    Antacid helps tuberculosis bacteria to survive

    In 2017, some 10 million people suffered from tuberculosis and 1.6 million died of the disease. One reason why infection…

    Lees meer
  • Current recommended treatment regimen for highly drug-resistant TB (left) versus the BPaL regimen (right).

    14/08/2019

    FDA approval of BPaL regimen an important breakthrough in TB control

    The US Food & Drug Administration (FDA) today approved pretomanid for the treatment of highly drug-resistant forms of tuberculosis (TB)…

    Lees meer

  • 23/07/2019

    ASCENT: Empowering patients through digital technology

    GENEVA/THE HAGUE, The next three and a half years, KNCV Tuberculosis Foundation will lead the innovative ASCENT project, which stands…

    Lees meer

  • 20/06/2019

    Call to Action for awareness on AMR

    KNCV Tuberculosis Foundation is one of the civil society organizations that signs the Call to Action for awareness on antimicrobial…

    Lees meer

  • 28/05/2019

    Wolfheze Workshops 2019: inspiring knowledge exchange & concrete steps forward

    KNCV Tuberculosis Foundations can look back at an inspiring edition of the Wolfheze Workshops 2019 (15-17…

    Lees meer

  • 15/05/2019

    Unique gathering of TB and HIV experts in Scheveningen

    Biennial Wolfheze Workshops focuses on alarming tandem of infectious diseases THE HAGUE, 15 May 2019 International experts in the field…

    Lees meer

  • 12/04/2019

    Dutch civil society calls upon increase of Dutch commitment to the Global Fund

    The Hague – This week, KNCV Tuberculosis Foundation, in cooperation with Aidsfonds and nine other Dutch civil society organisations* called…

    Lees meer

  • 24/03/2019

    IT’S TIME … for new TB drugs and treatment regimens for all

    THE HAGUE – Today, on World TB Day, the international TB community raises awareness about the deadliest infectious disease in…

    Lees meer

  • 19/03/2019

    TB remains major public health challenge in European region

    The latest WHO/ECDC report Tuberculosis surveillance and monitoring in Europe 2019 (2017 data) shows that despite an overall decline in…

    Lees meer

  • 14/03/2019

    Promising results from new drugs and shorter regimen in Kyrgyzstan

    The Government of the Kyrgyz Republic and USAID announced major advancements in the fight against the ongoing tuberculosis epidemic in…

    Lees meer

  • 08/03/2019

    Short Regimen for Preventing TB Found Safe When Co-administered with New First-line HIV Drug

    New study paves the way for scale-up of TB prevention among people living with HIV, who are dying from TB…

    Lees meer

  • 06/03/2019

    Global Fund Director Peter Sands visited KNCV and the Dutch Parliament

    The Hague – Peter Sands, Director of the Global Fund to Fight AIDS, Tuberculosis and Malaria, recently visited the Netherlands.

    Lees meer
Bezoek Nederlandse website

KNCV has been fighting TB since its establishment in 1903. Over the past 120 years, the organization has acquired indispensable knowledge and experience in the field of effective TB prevention and care, resulting in pre-elimination in the Netherlands and significant contributions to global evidence generation, policy development and TB program implementation worldwide.

Our experts
KNCV governance framework and integrity
Our patroness
Partner with us

Cambodia
Eswatini
Ethiopia
Indonesia
Kazakhstan
Kenya
Kyrgyzstan
Namibia
Nigeria
Tajikistan
Tanzania
Ukraine
Vietnam
Zambia

Tuberculosis is still one of the major causes of preventable death in the world and claims over 4000 lives a day, leading to over 1,5 million deaths a year.

Patient stories

The story of Abdurahim
The story of Fikeraddis
The story of Issayas
The story of Zarina
The story of Maxine
The story of Saanvi

KNCV’s Key Technical Assistance Intervention Pathways

Improved scientific methods and models to end TB

Stronger health systems, data driven planning

Zero TB related stigma

Optimized digital health solutions along the patient pathway

TB vaccine access strategies

New Diagnostics and Laboratory Network Design

New drugs & treatment regimens

Diagnosis & treatment of LTBI

People-Centred Framework for TB Programming: Development of Optimized National Strategic Plans

Childhood TB – KNCV Benchmarking Tool for TB in Children and Adolescents

Current Projects

ASCENT
ASTTIE
ETBE Project
Evaluation of SeroSelectTB
GeneXpert MTB/RIF Test
iDEFEAT TB Project
IMPAACT4C19
IMPAACT4TB
LIFT-TB 
No More Pandemics
PANGenS
People-Centered Framework for TB Programming (PCF)
Triage Test for All Oral DR TB Regimen (TriAD)
SMART4TB
The Global Fund to Fight AIDS, Tuberculosis and Malaria

Completed Projects

Challenge TB
Development of a comprehensive Digital Training Package
E-detect
Improved TB/HIV Prevention & Care – Building Models for the Future Project
PAVIA
PODTEC
TB REACH Ethiopia
TB REACH Nigeria
TB REACH Philippines
TB REACH Tanzania
TREATS

KNCV Webinar: Impact of COVID-19: Hear the perspective of TB/MDR-TB patients and front line health care workers
KNCV Webinar: Contact Investigation for COVID-19: Lessons from TB Control Programs
KNCV Webinar ‘Infection prevention and control for COVID-19

KNCV’s Technical Assistance package

Annual Reports

KNCV’s SOS Stoolbox

KNCV Benchmarking Tool for TB in Children and Adolescents

KNCV’s People Centered Framework (Handbook, Dashboard, Toolkit)

KNCV’s Success Stories from IMPAACT4TB – 4 countries

KNCV’s Success Stories from IMPAACT4TB – Malawi

TB Stigma Measurement Guidance

From the Inside Out – Dealing with TB-related Self-stigma and Shame

Allies Approach – The KNCV Stigma Reduction Toolbox

KNCV 2-pager TB Photovoices

Sorry

De versie van de browser die je gebruikt is verouderd en wordt niet ondersteund.
Upgrade je browser om de website optimaal te gebruiken.